Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

CDC to Build New BSL-4 High-Containment Continuity Laboratory (HCCL)

by Global Biodefense Staff
October 1, 2018
BSL Level 4 Biodefense Lab (NIAID)

The Centers for Disease Control and Prevention (CDC) operates high-containment laboratories (HCLs) to study some of the most virulent threats to public health. Outbreaks involving pathogens such as the Ebola and Zika viruses place increased pressure on our national research resources to maintain appropriate biocontainment environments. CDC’s need for continuous high-biosafety level (BSL) containment laboratory space is growing as the threats from existing and emerging high-consequence pathogens are discovered. The design and construction of the High-Containment Continuity Laboratory (HCCL) on the Roybal Campus in Atlanta, Georgia will meet these needs.

The CDC has issued a pre-solicitation for Architectural/Engineering (A/E) design and related service for the HCCL. The Architect-Engineer shall furnish architectural, laboratory planning, mechanical, electrical, plumbing, fire protection, structural, civil, and any other design disciplines required to perform pre-design studies, program development, investigations, evaluations, design and construction document production, cost estimates, construction administration services, commissioning support, participation in an independent value engineering process, and other related professional services.

The HCCL will be a highly flexible biological laboratory comprised of BSL-3E and BSL-4 laboratories and associated support. The multi-story research building will house adequate laboratory space for eighty laboratorians. The HCCL will have gross building area of approximately 100,000 square feet.

All biosafety features and systems of high containment laboratories will be included such as HEPA filtered supply and exhaust air, air pressure resistant doors, pressure cascade zoning, effluent collection and treatment, pressure decay tested coatings and penetrations, and other systems such as high purity breathing air and chemical decontamination showers that support BSL4 workers donning air pressure resistant suits. The HCCL’s architectural character and massing will complement the finishes, textures, and colors of the adjacent Roybal Campus laboratory buildings. The Project includes utility infrastructure extensions necessary to connect the building to existing Roybal Campus utility systems with below grade utility tunnels for chilled water and steam services.

The Government anticipates that the Phase I Solicitation will be posted on or around August 20, 2018 to FedBizOpps.gov. Additional details are available via Solicitation Number: 75D301-18-R-67933.

Tags: BiosafetyBSL-4RFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
New Framework for Livestock Disease Indemnity Valuation Proposed by USDA
Biosecurity

New Framework for Livestock Disease Indemnity Valuation Proposed by USDA

September 10, 2022
Waterfowl on a seashore
Biosecurity

HPAI Concerns Prompt U.S. Restrictions on Hunter Harvested Wild Bird Game Meat from Canada

September 2, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy